Basilea Pharmaceutica
BSLN.SW
₹6,319
Share price
2.81%
Change (1 day)
69.70%
Change (1 year)
Categories
Earnings for Basilea Pharmaceutica (BSLN.SW)
Earnings in 2024: ₹5.78 Billion
According to Basilea Pharmaceutica's latest financial reports the company's current earnings are ₹0.23 Billion. In 2024 the company made an earning of ₹5.78 Billion, an increase over its 2023 earnings that were of ₹1.07 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Basilea Pharmaceutica from 2002 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2024 | ₹5.78 B | 436.2% |
| 2023 | ₹1.07 B | -5.02% |
| 2022 | ₹1.13 B | -276.18% |
| 2021 | -₹0.65 Billion | -55.31% |
| 2020 | -₹1.45 Billion | -28% |
| 2019 | -₹2.01 Billion | -27.06% |
| 2018 | -₹2.75 Billion | 62.13% |
| 2017 | -₹1.7 Billion | -60.94% |
| 2016 | -₹4.34 Billion | -19.67% |
| 2015 | -₹5.4 Billion | 48.25% |
| 2014 | -₹3.64 Billion | 12.95% |
| 2013 | -₹3.23 Billion | -35.16% |
| 2012 | -₹4.97 Billion | -5.75% |
| 2011 | -₹5.28 Billion | -152.57% |
| 2010 | ₹10.03 B | -199.59% |
| 2009 | -₹10.08 Billion | -15.54% |
| 2008 | -₹11.93 Billion | 22.84% |
| 2007 | -₹9.71 Billion | 60.07% |
| 2006 | -₹6.07 Billion | 85.69% |
| 2005 | -₹3.27 Billion | -43.04% |
| 2004 | -₹5.74 Billion | 47.04% |
| 2003 | -₹3.9 Billion | -39.23% |
| 2002 | -₹6.42 Billion |